NCT00252122 Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease Status TERMINATED Phase PHASE4
NCT00235391 Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload Status COMPLETED Phase PHASE3
NCT00228631 Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD Status COMPLETED Phase N/A
NCT00186810 Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease Status COMPLETED Phase PHASE2
NCT00153985 Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies Status COMPLETED Phase PHASE2
NCT00152113 Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound Status COMPLETED Phase PHASE1
NCT00110617 Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients Status COMPLETED Phase PHASE2
NCT00072826 Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT00061568 Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT00047996 Blood Collection for Research Related to Certain Diseases Involving Blood Vessels Status ENROLLING_BY_INVITATION Phase N/A
NCT00041574 Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide Status TERMINATED Phase PHASE2
NCT00040677 A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia. Status COMPLETED Phase PHASE2